Feature | September 07, 2010| Dave Fornell

Forward-Looking IVUS May Aid CTO Visualization

FL-IVUS has promise to help speed chronic total occlusion procedures

A major issue in treating chronic total occlusions (CTOs) is the lack of angiographic visualization. The flow of blood and contrast is completely blocked, eliminating the ability to navigate the vessel or see where wires are being poked. Not being able to see what you are treating is a big reason why operators do not attempt these lesions.

“All you see is the start and the end of the lesion. It can be very terrifying,” said William Lombardi, M.D., FSCAI, medical director of cardiac cath labs at St. Joseph Hospital, Bellingham, Wash.

In a comparison of items needed to treat CTOs, Scott Huennekens, president and CEO of Volcano Corp., said to build a car you need wheels, steering and headlights. There are already interventional tools available to steer and treat CTOs, but operators still need a way to see where they are driving. “You are always driving in the dark. You have wheels and steering, but you have no headlights, so you can’t see where you are going,” Huennekens said.

Volcano is developing two forward-looking intravascular ultrasound systems (FL-IVUS). One is for visualization ahead of the catheter and the second will incorporate a radio frequency (RF) ablation tip.

Aaron Grantham, M.D., FACC, Mid-America Heart Institute, Kansas City, Mo., is not convinced that incorporating the RF tip will completely solve CTO treatment issues. He said prior RF catheters were unsuccessful. However, he thinks FL-IVUS has the potential to make visualizing and traversing CTOs with wires easier and safer. He is very interested to hear reports about the first-in-man experience scheduled to start this fall in the Netherlands and Chile. “Translation from bench models to bedside will be a major milestone for FL-IVUS,” he said.

Volcano hopes for European CE-mark clearance of its FL-IVUS device by mid-2011, and in the U.S. by the end of 2011. The company said its first-in-man trial for the FL-IVUS ablation system is set to begin by mid-2011.

“In theory, forward-looking IVUS has promise. However, some operators already have a 95 percent success rate, so it will have to show it can do the procedure faster,” Lombardi said. “All technology is going to do is shorten the procedure.”

Related Content

St. Jude Medical, Optis Mobile Sytem, Europe and Japan launch, OCT and angiography
Technology | Intravascular Imaging| February 08, 2016
St. Jude Medical Inc. announced the launch of the company’s Optis Mobile System in Japan and Europe. The diagnostic...
Cath lab radiation dose reduaction, doseaware, raysafe

The Philips DoseAware Xtend system is an advanced version of the Unfors RaySafe system, combining real time radiation detection badges and a live video screen showing each person in the cath lab in a different color. The system reports their real-time exposure rate and cumulative dose since the start of a procedure. It shows changes in dose exposure the closer a person gets to the C-arm.

Feature | Cardiac Imaging| January 12, 2016 | Dave Fornell
Each year radiology vendors use the Radiological Society of North America (RSNA) meeting as a springboard to unveil t
vessel assist, CTO fusion imaging

An example of Vessel Assist used to create vessel centerlines through a CTO to help guide revascularization in the cath lab.

Technology | Cath Lab Navigation Aids| December 14, 2015
December 14, 2015 — As the field of interventional medicine grows, so do the challenges for clinicians to plan, guide
Sponsored Content | Videos | Cardiac Imaging| December 11, 2015
ITN/DAIC Editor Dave Fornell shows his choices for some of the most innovative new imaging technologies on the expo f
Sponsored Content | Videos | TCT| November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015 T
Sponsored Content | Videos | TCT| November 05, 2015
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies pr
Sponsored Content | Videos | Intravascular Imaging| October 30, 2015
Ziad  Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyte
News | Cath Lab| October 09, 2015
October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiova
Infraredx, NIRS, IVUS
News | Intravascular Imaging| September 11, 2015
September, 11, 2015 – Japanese medical vendor Nipro Corp.
Pie Medical Imaging, Frost & Sullivan, technology leadership, CAAS, cardiovascular diagnostics

CAAS MRV is part of Pie Medical Imaging's suite of imaging solutions for quantitative cardiovascular diagnosis and treatment planning. - See more at: http://www.itnonline.com/content/pie-medical-imaging-recognized-innovati...

News | Cardiac Imaging| September 01, 2015
Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical...
Overlay Init